The evaluation of the COX-2 selective inhibition of lumiracoxib, a novel nonsteroidal antiinflammatory drug.

被引:1
|
作者
Furuie, H [1 ]
Murakami, M [1 ]
Matsuguma, K [1 ]
Ishibashi, M [1 ]
Tsukikawa, H [1 ]
Kimura, M [1 ]
Shishido, A [1 ]
Irie, S [1 ]
机构
[1] Novartis Pharma KK, Kyushu Clin Pharmacol Res Clin, Fukuoka, Japan
关键词
D O I
10.1016/j.clpt.2003.11.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:P5 / P5
页数:1
相关论文
共 50 条
  • [41] The David Y. Graham lecture: Use of nonsteroidal Antiinflammatory drugs in a COX-2 restricted environment
    Chan, Francis K. L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (01): : 221 - 227
  • [42] Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity
    Lazer, ES
    Miao, CK
    Cywin, CL
    Sorcek, R
    Wong, HC
    Meng, ZX
    Potocki, I
    Hoermann, M
    Snow, RJ
    Tschantz, MA
    Kelly, TA
    McNeill, DW
    Coutts, SJ
    Churchill, L
    Graham, AG
    David, E
    Grob, PM
    Engel, W
    Meier, H
    Trummlitz, G
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) : 980 - 989
  • [43] Clinical pharmacology of novel selective COX-2 inhibitors
    Tacconelli, S
    Capone, ML
    Patrignani, P
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (06) : 589 - 601
  • [44] Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents
    Abolhasani, Hoda
    Zarghi, Afshin
    Movahhed, Tahereh Komeili
    Abolhasani, Ahmad
    Daraei, Bahram
    Dastmalchi, Siavoush
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 32
  • [45] Characterization of etoricoxib, a novel, selective COX-2 inhibitor
    Dallob, A
    Hawkey, CJ
    Greenberg, H
    Wight, N
    De Schepper, P
    Waldman, S
    Wong, P
    DeTora, L
    Gertz, B
    Agrawal, N
    Wagner, J
    Gottesdiener, K
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (06): : 573 - 585
  • [46] COX-2 selective inhibition reverses the trophic properties of gastrin
    Yao, M
    Rana, B
    Wolfe, MM
    GASTROENTEROLOGY, 2001, 120 (05) : A39 - A39
  • [47] Selective COX-2 inhibition in the canine groove model of osteoarthritis
    Mastbergen, SC
    Marijnissen, AC
    Vianen, ME
    van Roermund, PM
    Bijlsma, JW
    Lafeber, FJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S60 - S60
  • [48] Improved islet graft function by selective inhibition of COX-2
    Poggioli, R
    Molano, RD
    Pileggi, A
    Zahr, E
    Ricordi, C
    Inverardi, L
    CELL TRANSPLANTATION, 2003, 12 (02) : 141 - 141
  • [49] Effect of selective COX-2 inhibition on coronary artery reactivity
    Huang, JB
    Hong, TT
    Lucchesi, BR
    FASEB JOURNAL, 2005, 19 (05): : A1088 - A1088
  • [50] IMPAIRED FRACTURE HEALING BY HIGHLY SELECTIVE COX-2 INHIBITION
    Janssen, M. P.
    Caron, M. M.
    van Rietbergen, B.
    Welting, T. J.
    Emans, P. J.
    OSTEOARTHRITIS AND CARTILAGE, 2013, 21 : S12 - S12